Document is current
Any future updates will be listed below
-
Authors
Tuncel, Murat
Vrachimis, Alexis
Campenni, Alfredo
de Keizer, Bart
Verburg, Frederik A.
Kreissl, Michael C.
Ovcaricek, Petra Petranovic
Geliashvili, Tamara
Giovanella, Luca
- License Information
-
More Information
Article History
First Online: 18 May 2022
Declarations
:
: Institutional Review Board approval was not required because the paper is an Editorial.
: Not applicable.
: Michael C. Kreissl has served on advisory boards for Bayer HealthCare, Eisai, Exelixis, and Ipsen and has received event sponsorship from Bayer HealthCare, Eisai, Ipsen, GE Healthcare, Siemens, and Curium; speaker honoraria from Eisai, Exelixis, GE Healthcare, Takeda, Sanofi, Genzyme, and Ipsen; research funding from GE Healthcare and Sanofi Genzyme; and travel funding from Ipsen and Sanofi Genzyme. Frederik A. Verburg has received speaker honoraria from Sanofi and AstraZeneca, and research funding from EISAI. All other authors declare no competing interests.
Free to read: This content has been made available to all.
